Skip to main content
. 2021 Aug 26;18(17):9001. doi: 10.3390/ijerph18179001

Table 2.

Results for the primary outcome measures.

T1 T2
Group M
(Median)
SD
(Range)
M
(Median)
SD
(Range)
Delta
[95% CI]
d
[95% CI]
RM-ANOVA
F(df), p
Dyspnea
NRS “How intense is your dyspnea at rest?” (☺ 0–10 ☹)
All patients
N = 82
1.70
(1.00)
1.82
(0.00–8.00)
1.02
(0.00)
1.49
(0.00–7.00)
−0.67
[−1.03; −0.32]
−0.41
[−0.64; −0.19]
FT = 13.3(1),
p < 0.001
FG = 2.4(2),
p = 0.100
FG*T = 0.24(2),
p = 0.788
A
N = 43
1.44
(1.00)
1.68
(0.00–8.00)
0.84
(0.00)
1.34
(0.00–7.00)
−0.60
[−1.06; −0.15]
− 0.41
[−0.72; −0.10]
B
N = 24
1.63
(1.00)
1.41
(0.00–5.00)
1.00
(1.00)
1.10
(0.00–3.00)
−0.63
[−1.22; −0.03]
−0.49
[−0.86; −0.02]
C
N = 15
2.53
(2.00)
2.53
(0.00–7.00)
1.60
(0.50)
2.23
(0.00–7.00)
−0.93
[−2.21; −0.35]
−0.39
[−0.92; 0.13]
NRS “How intense is your dyspnea on exertion?” (☺ 0–10 ☹)
All patients
N = 82
5.56
(6.00)
2.50
(0.00–10.00)
3.41
(3.00)
2.73
(0.00–10.00)
−2.15
[−2.73; −1.57]
−0.82
[−1.01; −0.56]
FT = 39.0(1),
p < 0.001
FG = 0.25(2),
p = 0.774
FG*T = 65(2),
p = 0.524
A
N = 43
5.60
(5.50)
2.56
(0.00–10.00)
3.23
(2.00)
2.58
(0.00–10.00)
−2.37
[−3.16; −1.58]
−0.92
[−1.28; −0.56]
B
N = 24
5.46
(6.00)
2.47
(1.00–9.00)
3.29
(2.00)
2.66
(0.00–8.00)
−2.17
[−3.37; −0.96]
−0.85
[−1.21; −0.30]
C
N = 15
5.60
(6.00)
2.53
(0.00–9.00)
4.13
(4.00)
3.29
(0.00–10.00)
−1.47
[−2.87; −0.06]
−0.58
[−1.12; −0.02]
mMRC (☺ 0–4 ☹)
All patients
N = 90
2.26
(2.00)
1.19
(0.00 – 4.00)
1.51
(2.00)
1.12
(0.00–4.00)
−0.74
[−0.99; −0.50]
−0.64
[−0.87; −0.42]
FT = 25.1(1),
p < 0.001
FG = 1.81(2),
p = 0.168
FG*T = 1.14(2),
p = 0.323
A
N = 48
2.52
(2.00)
1.29
(0.00–4.00)
1.60
(2.00)
1.09
(0.00–4.00)
−0.92
[−1.27; −0.57]
−0.76
[−1.08; −0.44]
B
N = 26
1.88
(2.00)
0.82
(0.00–4.00)
1.35
(2.00)
1.23
(0.00–4.00)
−0.53
[−1.04; −0.04]
−0.43
[−0.83; −0.03]
C
N = 16
2.06
(2.00)
1.24
(0.00–4.00)
1.50
(1.50)
1.10
(0.00–4.00)
−0.56
[−1.00; −0.13]
−0.69
[−1.23; −0.12]

Notes: T1: start of rehabilitation; T2: end of rehabilitation; M: mean; SD: standard deviation; Delta: difference MT2−MT1; 95% CI: 95% confidence interval; d: Cohen’s d; RM-ANOVA: repeated-measures analysis of variance; FT: F-value for factor “Time” (T1 versus T2); FG: F value for factor “Group” (A versus B versus C); FG*T: F value for interaction of “Time” and “Group”; NRS: Numeric Rating Scale; mMRC: modified Medical Research Council.